» Authors » Emiliano Marasco

Emiliano Marasco

Explore the profile of Emiliano Marasco including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 622
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Moran Alvarez P, Bracaglia C, Nicolai R, Giovannelli L, Caiello I, Boni A, et al.
Lupus . 2024 Nov; 33(14):1594-1604. PMID: 39494571
Objective: to investigate the trend of autoantibody titers during a 2-year follow-up in pediatric systemic lupus erythematosus (pSLE) and pediatric Sjögren's syndrome (pSS). Methods: Autoantibodies testing was performed every 3-4...
2.
Tarantino G, Nicolai R, Aquilani A, Tomasini A, Celano A, Pucacco A, et al.
Clin Exp Rheumatol . 2024 Jul; 42(11):2288-2294. PMID: 38976308
Objectives: Methotrexate (MTX) is the most used drug to treat children and adults with arthritis and its use is burdened by adverse effects. The MTX intolerance severity score (MISS) was...
3.
Nicolai R, Merli P, Moran Alvarez P, Bracaglia C, Del Bufalo F, Marasco E, et al.
Arthritis Rheumatol . 2024 Jun; 76(10):1560-1565. PMID: 38924652
Objective: The aim of this study is to report the safety and efficacy of CD19-targeting chimeric antigen receptor (CAR) T cells in a child with refractory juvenile dermatomyositis (JDM). Methods:...
4.
Boni A, Nicolai R, Caiello I, Marinaro F, Farina L, Pires Marafon D, et al.
RMD Open . 2024 Mar; 10(1). PMID: 38453214
Objectives: Paediatric Sjögren's syndrome (pSS) is a rare chronic autoimmune disorder, characterised by inflammation of exocrine glands. B cell hyperactivation plays a central role in adult-onset Sjogren. This study was...
5.
Marasco E, Fabbriciani G, Rotunno L, Longhi M, De Luca P, de Girolamo L, et al.
Front Immunol . 2023 Oct; 14:1254139. PMID: 37809106
Introduction: Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that may cause joint destruction and disability. The pharmacological treatment of RA aims at obtaining disease remission by effectively ceasing joint...
6.
Moneta G, Bracaglia C, Caiello I, Farroni C, Pires Marafon D, Carlomagno R, et al.
Eur J Immunol . 2023 May; 53(7):e2250319. PMID: 37204055
Systemic lupus erythematosus (SLE) is an autoimmune disease causing significant morbidity and mortality, despite important improvements in its management in the last decades. The objective of this work is to...
7.
Friman V, Quinti I, Davydov A, Shugay M, Farroni C, Engstrom E, et al.
Cell Rep . 2023 Apr; 42(5):112446. PMID: 37119135
Common variable immune deficiency (CVID) is a heterogeneous disorder characterized by recurrent infections, low levels of serum immunoglobulins, and impaired vaccine responses. Autoimmune manifestations are common, but B cell central...
8.
9.
Fredi M, Cavazzana I, Ceribelli A, Cavagna L, Barsotti S, Bartoloni E, et al.
Clin Rev Allergy Immunol . 2022 Jan; 63(2):240-250. PMID: 35092577
The identification of anti-NXP2 antibodies is considered a serological marker of dermatomyositis (DM), with calcinosis, severe myositis and, in some reports, with cancer. Historically, these associations with anti-NXP2 antibodies have...
10.
De Benedetti F, Prencipe G, Bracaglia C, Marasco E, Grom A
Nat Rev Rheumatol . 2021 Oct; 17(11):678-691. PMID: 34611329
Interferon-γ (IFNγ) is a pleiotropic cytokine with multiple effects on the inflammatory response and on innate and adaptive immunity. Overproduction of IFNγ underlies several, potentially fatal, hyperinflammatory or immune-mediated diseases....